1Murray N, Turrisi AT 3rd. A review of first-line treatment for small-cell lung cancer[J]. J Thorac Oncol, 2006,1 (3) : 270.
2Takada M, Fukuoka M, Kawahara M, et al. Phase Ⅲ study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104 [J]. J Clin Oncol,2002,20(14) :3054.
3Turrisi AT 3rd,Kim K,Blum R,et al. Twice daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide[J]. N Engl J Med,1999,340(4) :265.
4Pijls-Johannesma M, De Ruysscher D, Vansteenkiste J, et al. Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of ran- domised controlled trials [J]. Cancer Treat Rev, 2007,33 ( 5 ) : 461.
5De Ruysscher D, Pijls-Johannesma M, Bentzen SM, et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited- disease small-cell lung cancer[J]. J Clin Oncol, 2006, 24 (7): 1057.
6Schild SE,Bonner JA,Shanahan TG,et al. Long-term results of a phase Ⅲ trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung caneer[J]. Int J Ra- diat Oncol Biol Phys,2004,59(4):943.
7Foster NR, Mandrekar SJ, Schild SE, et al. Prognostic factors dif- fer by tumor stage for small cell lung cancer:a pooled analysis of North Central Cancer Treatment Group trials[J]. Cancer, 2009, 115(12):2721.
8Albain KS, Crowley JJ, LeBlanc M, et al. Determinants of im- proved outcome in small-cell lung cancer: an analysis of the 2, 580-patient Southwest Oncology Group data base[J]. J Clin On- col, 1990,8(9) : 1563.
9Yip D,PG Harper. Predictive and prognostic factors in small cell lung cancer:current status. Lung Cancer,2000,28(3):173.
